Merial’s Closes Acquisition of Animal Health Division of Dosch Pharmaceuticals
INDIA - Merial, the animal health division of Sanofi, today announced the approval and closing of Merial’s acquisition of the animal health division of Dosch Pharmaceuticals Private Limited, creating for Merial a market entry in India’s growing animal health market.
8 July 2013
2 minute read
The signing of a binding agreement leading up to the acquisition was announced in December 2012. Merial and Dosch have now completed all regulatory approvals required for the closing of the acquisition.
The acquired business, now the animal health division of Sanofi Synthelabo India, will commence marketing Dosch’s 86 animal health products and 50 brands for ruminants, poultry and companion animals, as well as continue the process of registering Merial brands for companion and production animals for commercialization in India.
Dosch animal health division CEO, Dr. Sharat Tugnait, and his management team will continue to oversee the combined Merial/Dosch operations in Mumbai, India, under the executive direction of Merial India country manager, Mayank Parekh.
